206 participants
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-19
- Start Date:
- 2019-03-01
- Completion:
- 2024-08-05
Conditions
- Neoplasms
Interventions
- DRUG
No Results Yet